Western Standard LLC Keros Therapeutics, Inc. Transaction History
Western Standard LLC
- $337 Million
- Q3 2025
A detailed history of Western Standard LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Western Standard LLC holds 2,189,882 shares of KROS stock, worth $37.8 Million. This represents 10.27% of its overall portfolio holdings.
Number of Shares
2,189,882
Previous 1,534,893
42.67%
Holding current value
$37.8 Million
Previous $20.5 Million
69.07%
% of portfolio
10.27%
Previous 11.4%
Shares
3 transactions
Others Institutions Holding KROS
# of Institutions
169Shares Held
35.4MCall Options Held
574KPut Options Held
325K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$93 Million8.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.72MShares$46.9 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY2.71MShares$46.7 Million3.92% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$43.4 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.42MShares$24.5 Million1.02% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $445M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...